The Advisory Team at Cardiff Oncology provides expert guidance and strategic insights to support the development and clinical advancement of onvansertib. Comprised of experienced advisors and independent directors, the team leverages their extensive knowledge in oncology and clinical research to help address medical needs, overcome treatment resistance, and improve patient outcomes.
View all